Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinomaWANG QIAN; LI-FU HU; FU CHEN et al.European journal of cancer. Part B, Oral oncology. 1995, Vol 31, Num 5, pp 328-332, issn 0964-1955Article

Absence of WAF1 mutations in a variety of human malignanciesSHIOHARA, M; EL-DEIRY, W. S; WADA, M et al.Blood. 1994, Vol 84, Num 11, pp 3781-3784, issn 0006-4971Article

The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1LIANG, S. X; RICHARDSON, D. R.Carcinogenesis (New York. Print). 2003, Vol 24, Num 10, pp 1601-1614, issn 0143-3334, 14 p.Article

p53, p21 and p27 protein expression in head and neck cancer and their prognostic valueKAPRANOS, N; STATHOPOULOS, G. P; MANOLOPOULOS, L et al.Anticancer research. 2001, Vol 21, Num 1B, pp 521-528, issn 0250-7005Article

COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosisXIAOLING ZHOU; XIN WEI WANG; LIXIN XU et al.Cancer research (Baltimore). 1999, Vol 59, Num 4, pp 843-848, issn 0008-5472Article

Regulation of p21(WAF1) expression during normal myeloid differentiationSTEINMAN, R. A; JIANPING HUANG; YAROSLAVSKIY, B et al.Blood. 1998, Vol 91, Num 12, pp 4531-4542, issn 0006-4971Article

Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx : Possible implications of molecular biology and compartmentationWAGNER, Mathias; KLUSSMANN, Jens-Peter; FANGMANN, Rainer et al.Anticancer research. 2001, Vol 21, Num 1A, pp 333-345, issn 0250-7005Article

p21Cip1/WAF1 is important for differentiation and survival of U937 cellsASADA, M; YAMADA, T; FUKUMURO, K et al.Leukemia. 1998, Vol 12, Num 12, pp 1944-1950, issn 0887-6924Article

Loss of p21^WAF1/CIP1 expression correlates with disease progression in gastric carcinomaOGAWA, M; MAEDA, K; ONODA, N et al.British journal of cancer. 1997, Vol 75, Num 11, pp 1617-1620, issn 0007-0920Article

WAF1/CIP1 protein expression in human breast tumorsDIAB, S. G; YU, Y.-Y; HILSENBECK, S. G et al.Breast cancer research and treatment. 1997, Vol 43, Num 2, pp 99-103, issn 0167-6806Article

High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemiaZHANG, W; KORNBLAU, S. M; KOBAYASHI, T et al.Clinical cancer research. 1995, Vol 1, Num 9, pp 1051-1057, issn 1078-0432Article

Tumor suppression by p21^WAF1CHEN, Y. Q; CIPRIANO, S. C; ARENKIEL, J. M et al.Cancer research (Baltimore). 1995, Vol 55, Num 20, pp 4536-4539, issn 0008-5472Article

Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancersMASUDA, Norihiro; KATO, Hiroyuki; NAKAJIMA, Takashi et al.Cancer science. 2003, Vol 94, Num 7, pp 612-617, issn 1347-9032, 6 p.Article

A protective role for common P21^WAF1/Cip1 polymorphisms in human ovarian cancerMILNER, B. J; BROWN, I; GABRA, H et al.International journal of oncology. 1999, Vol 15, Num 1, pp 117-119, issn 1019-6439Article

Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomasSHI, Y; ZOU, M; FARID, N. R et al.British journal of cancer. 1996, Vol 74, Num 9, pp 1336-1341, issn 0007-0920Article

Inhibitors of cyclin-dependent kinase and cancerBIGGS, J. R; KRAFT, A. S.Journal of molecular medicine (Berlin. Print). 1995, Vol 73, Num 10, pp 509-514, issn 0946-2716Article

WAF1, a potential mediator of p53 tumor suppressionEL-DEIRY, W. S; TOKINO, T; VELCULESCU, V. E et al.Cell (Cambridge). 1993, Vol 75, Num 4, pp 817-825, issn 0092-8674Article

Quantitative p21^WAF-1/P53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicatorsCECCARELLI, C; SANTINI, D; CHIECO, P et al.International journal of cancer. 2001, Vol 95, Num 2, pp 128-134, issn 0020-7136Article

Activation of p53/p21^waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblastsD'ORAZI, Gabriella; SODDU, Silvia; SACCHI, A. D. A et al.Anticancer research. 2000, Vol 20, Num 5B, pp 3497-3502, issn 0250-7005Article

The prognostic significance of p53, p21(Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patientsHIRAI, T; KUWAHARA, M; YOSHIDA, K et al.Anticancer research. 1999, Vol 19, Num 5C, pp 4587-4591, issn 0250-7005Article

Posttranscriptional regulation of p21^WAF1/CIP1 expression in human breast carcinoma cellsLI, X.-S; RISHI, A. K; SHAO, Z.-M et al.Cancer research (Baltimore). 1996, Vol 56, Num 21, pp 5055-5062, issn 0008-5472Article

Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblastsENNS, L; MURRAY, D; MIRZAYANS, R et al.British journal of cancer. 1999, Vol 81, Num 6, pp 959-965, issn 0007-0920Article

p53 and p21^WAF1 expression in lymphocytic thyroiditis and thyroid tumorsOKAYASU, I; OSAKABE, T; ONOZAWA, M et al.Clinical immunology and immunopathology (Print). 1998, Vol 88, Num 2, pp 183-191, issn 0090-1229Article

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21^WAF1/Cip1 in colorectal carcinomaSLEBOS, R. J. C; BAAS, I. O; CLEMENT, M et al.British journal of cancer. 1996, Vol 74, Num 2, pp 165-171, issn 0007-0920Article

Repair defect in p21^WAF1/CIP1 -/- human cancer cellsMCDONALD, E. R; GEN SHENG WU; WALDMAN, T et al.Cancer research (Baltimore). 1996, Vol 56, Num 10, pp 2250-2255, issn 0008-5472Article